Bibliografía del artículo
1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558-567.
2. Sánchez Quijano A, Abad MA, Torronteras R, y col. Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol 1997; 27:25-29.
3. Cha TA, Beall B, Irvine J, y col. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 1992; 89:7144-7148.
4. Silva GF, Nishimura NF, Coelho KI, Soares EC. Grading and staging chronic hepatitis C and its relation to genotypes and epidemiological factors in Brazilian blood donors. Braz J Infect Dis 2005; 9:142-149.
5. Focaccia R, Baraldo DC, Ferraz ML. Demographic and anthropometrical analysis and genotype distribution of chronic hepatitis C patients treated in public and private reference centers in Brazil. Braz J Infect Dis 2004; 8:348-355.
6. Amorim RM, Oliveira CP, Wyant PS, y col. Hepatitis C virus genotypes in blood donors from the Federal District, Central Brazil. Mem Inst Oswaldo Cruz 2004; 99:895-897.
7. Soza A, Arrese M, González R, y col. Clinical and epidemiological features of 147 Chilean patients with chronic hepatitis C. Ann Hepatol 2004; 3:146-151.
8. Cantaloube JF, Gallian P, Attoui H, Biagini P, De Micco P, De Lamballerie X. Genotype distribution and molecular epidemiology of hepatitis C virus in blood donors from southeast France. J Clin Microbiol 2005; 43:3624-3629.
9. Roque Afonso AM, Ducoulombier D, Di Liberto G, y col. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005; 79:6349-6357.
10. Blatt LM, Mutchnick MG, Tong MJ y col. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat 2000; 7:196-202.
11. Smith DB, Davidson F, Yap P, y col. International HCV Collaborative Study Group. Levels of hepatitis C virus in blood donors infected with different viral genotypes. J Infect Dis 1996; 173:727-730.
12. Lau JY, Davis GL, Prescott LE, y col. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 1996; 124:868-876.
13. Margraf RL, Erali M, Liew M, Wittwer CT. Genotyping hepatitis C virus by heteroduplex mobility analysis using temperature gradient capillary electrophoresis. J Clin Microbiol 2004; 42:4545-4551.
14. Bonacini M, Govindarajan S, Blatt LM, Schmid P, Conrad A, Lindsay KL et al. Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. J Viral Hepat 1999; 6:203-8.
15. Yoo TW, Donfield S, Lail A, Lynn HS, Daar ES. Hemophilia growth and development study. Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis 2005; 191:4-10.
16. Van Asten L, Prins M. Infection with concurrent multiple hepatitis C virus genotypes is associated with faster HIV disease progression. AIDS 2004; 18:2319-2324.
17. Hultgren C, Desombere I, Leroux-Roels G, y col. Evidence for a relation between the viral load and genotype and hepatitis C virus-specific T cell responses. J Hepatol 2004; 40:971-978.
18. Rolfe KJ, Alexander GJ, Wreghitt TG, Parmar S, Jalal H, Curran MD. A real-time Taqman method for hepatitis C virus genotyping. J Clin Virol 2005; 11.
19. Laperche S, Lunel F, Izopet J, y col. Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study. J Clin Microbiol 2005; 43:733-739.
20. Zekri AR, El-Din HM, Bahnassy AA, y col. TRUGENE sequencing versus INNO-LiPA for sub-genotyping of HCV genotype-4. J Med Virol 2005; 75:412-420.
21. Lagging LM, García CE, Westin J, y col. Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J Clin Microbiol 2002; 40:4224-4229.
22. Gaudy C, Thevenas C, Tichet J, Mariotte N, Goudeau A, Dubois F. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. J Clin Microbiol 2005; 43:1722-1726.
23. Gonzalez V, Padilla E, Diago M, y col. Clinical usefulness of total hepatitis C virus core antigen quantification to monitor the response to treatment with peginterferon alpha-2a plus ribavirin. J Viral Hepat 2005; 12:481-487.
24. Enomoto M, Nishiguchi S, Tamori A, y col. Chemiluminescence enzyme immunoassay for monitoring hepatitis C virus core protein during interferon-alpha2b and ribavirin therapy in patients with genotype 1 and high viral loads. J Med Virol 2005; 77:77-82.
25. Massaguer A, Forns X, Costa J, y col. Performance of hepatitis C virus core antigen immunoassay in monitoring viral load after liver transplantation. Transplantation 2005; 79:1441-1444.
26. Herring BL, Tsui R, Peddada L, Busch M, Delwart EL. Wide range of quasispecies diversity during primary hepatitis C virus infection. J Virol 2005; 79:4340-4346.
27. Seme K, Poljak M, Babic DZ, Mocilnik T, Vince A. The role of core antigen detection in management of hepatitis C: a critical review. J Clin Virol 2005; 32:92-101.
28. Laperche S, Le Marrec N, Girault A, y col. Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J Clin Microbiol 2005; 43:3877-3883.
29. Tang KH, Herrmann E, Cooksley H, y col. Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy. J Hepatol 2005 Aug 31; [Epub ahead of print].
30. Carlsson T, Reichard O, Norkrans G, y col. Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response. J Viral Hepat 2005; 12:473-480.
31. Kalantar-Zadeh K, Miller LG, Daar ES. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis 2005; 46:290-300.
32. Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH. Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR. Intervirology 2005; 48:213-215.
33. Glynn SA, Wright DJ, Kleinman SH, y col. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005; 45:994-1002.
34. Castillo I, Rodriguez-Inigo E, Bartolome J, y col. Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection. Gut 2005; 54:682-685.
35. Zhang W, Huang J, Zhou MF, y col. Protein chip for detection of different HCV antibodies: preparation, quality control, and clinical evaluation. Mol Diagn 2005; 9:81-87.
36. De Cock L, Hutse V, Vranckx R. Correlation between detection of antibodies against hepatitis C virus in oral fluid and hepatitis C virus RNA in serum. Eur J Clin Microbiol Infect Dis 2005 Aug 19; [Epub ahead of print].
37. Layden-Almer JE, Kuiken C, Ribeiro RM, y col. Hepatitis C virus genotype 1a NS5A pretreatment sequence variation and viral kinetics in African American and white patients. J Infect Dis 2005; 192:1078-1087.
38. Soderholm J, Ahlen G, Kaul A, y col. Relation between viral fitness and immune escape within the hepatitis C virus protease. Gut. 2005 Aug 16; [Epub ahead of print].
39. Hamano K, Sakamoto N, Enomoto N, y col. Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy. J Gastroenterol Hepatol 2005; 20:1401-1409.
40. Tanabe Y, Nagayama K, Enomoto N, y col. Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy. J Viral Hepat 2005; 12:251-261.
41. Yoshioka K, Ito H, Watanabe K, y col. Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection. J Viral Hepat 2005; 12:139-145.
42. Watanabe K, Yoshioka K, Yano M, y col. Mutations in the nonstructural region 5B of hepatitis C virus genotype 1b: their relation to viral load, response to interferon, and the nonstructural region 5A. J Med Virol 2005; 75:504-512. 43. Pascu M, Martus P, Hohne M, y col. Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences. Gut 2004; 53:1345-1351.
44. Schuttler CG, Thomas C, Discher T, Friese G, Lohmeyer J, Schuster R, Schaefer S, Gerlich WH. Variable ratio of hepatitis C virus RNA to viral core antigen in patient sera. J Clin Microbiol 2004; 42(5):1977-81.
45. Marinosci F, Bergamini C, Fransvea E, y col. Clinical role of serum and tissue matrix metalloprotease-9 expression in chronic HCV patients treated with pegylated IFN-alpha2b and ribavirin. J Interferon Cytokine Res 2005; 25:453-458.
46. Krekulova L, Rehak V, Riley LW. Hepatitis C virus (HCV) 5'NC sequence variants and their association with hepatitis C risk groups. J Clin Virol 2005; 32:300-304.
47. Chambers TJ, Fan X, Droll DA, y col. Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection. J Virol 2005; 79:3071-3083.
48. Bracho MA, Gosalbes MJ, Blasco D, Moya A, Gonzalez-Candelas F. Molecular epidemiology of a hepatitis C virus outbreak in a hemodialysis unit. J Clin Microbiol 2005; 43:2750-2755.
49. Othman SB, Trabelsi A, Monnet A, y col. Evaluation of a prototype HCV NS5b assay for typing strains of hepatitis C virus isolated from Tunisian haemodialysis patients. J Virol Methods 2004; 119:177-181.
50. Combet C, Penin F, Geourjon C, Deleage G. HCVDB: hepatitis C virus sequences database. Appl Bioinformatics 2004; 3:237-240.
51. Kuiken C, Yusim K, Boykin L, Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 2005; 21:379-384.